Information
-
Trademark
-
99182288
-
International Classifications
-
Filing Date
May 13, 2025
9 months ago
-
Transaction Date
May 14, 2025
9 months ago
-
Status Date
May 13, 2025
9 months ago
-
Status Code
630
-
-
Attorney Docket Number
A654-57
Attorney Name
Ben Natter
-
Owners
Mark Drawing Code
0
Mark Identification
KAMADA
Case File Statements
- DM0000: The mark consists of the stylized wording "KAMADA".
- GS0051: Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins; pharmaceuticals, namely, plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals, namely, coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia or analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for treatment of Rabies
Case File Event Statements
-
5/13/2025 - 9 months ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
5/13/2025 - 9 months ago
2 - APPLICATION FILING RECEIPT MAILED
Type: MAFR